Related Experiment Video

Updated: Mar 23, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.5K

Triptolide has anticancer and chemosensitization effects by down-regulating Akt activation through the MDM2/REST

Jing Xiong1, Tiefen Su1, Zhiling Qu1

  • 1Institute of Pathology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.

Oncotarget
|March 24, 2016
PubMed

Insights

Triptolide exhibits anticancer effects by inhibiting the MDM2/Akt pathway, independent of p53 status. This novel mechanism involves down-regulating Akt activation, leading to reduced proliferation and enhanced chemotherapy response in breast cancer.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Pharmacology

Background:

  • Triptolide demonstrates anticancer properties, but its precise mechanism remains unclear.
  • Understanding triptolide's molecular targets is crucial for developing effective cancer therapies.

Purpose of the Study:

  • To elucidate the novel signaling pathway involved in triptolide's anticancer activity.
  • To investigate the role of the MDM2/Akt pathway in triptolide's effects on breast cancer cells.
  • To explore triptolide's potential as a chemosensitizer.

Main Methods:

  • Investigated triptolide's effect on MDM2 expression and Akt activation in human breast cancer cells (wild-type and mutant p53).
  • Analyzed the interaction between MDM2 and REST, and its impact on PI3-kinase p85 expression.
  • Evaluated triptolide's effects on cell proliferation, apoptosis, cell cycle, and chemosensitization with doxorubicin.
  • Utilized MDM2 overexpression models and a mouse xenograft model to confirm the role of MDM2 inhibition.

Main Results:

  • Triptolide inhibits MDM2 expression, leading to decreased Akt activation, irrespective of p53 status.
  • Triptolide disrupts the MDM2-REST interaction, upregulating PI3-kinase p85 and inhibiting Akt.
  • Triptolide suppresses proliferation, induces apoptosis, causes G1 arrest, and enhances doxorubicin's cytotoxicity.
  • MDM2 inhibition is causative for triptolide's anticancer and chemosensitization effects, as demonstrated by overexpression studies and in vivo models.

Conclusions:

  • Triptolide exerts anticancer and chemosensitization effects by down-regulating Akt activation via the MDM2/REST pathway in human breast cancer.
  • This study reveals a p53-independent function of MDM2 in regulating Akt signaling, offering new insights into triptolide's mechanism of action.
  • Triptolide shows therapeutic potential as a novel anticancer agent and chemosensitizer, particularly in breast cancer treatment.
Keywords:
AktMDM2RESTbreast neoplasmstriptolide

More Related Videos

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

13.9K
Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

19.3K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.6K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K